Clinical Trial Update: Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating neoadjuvant CAPOX with or without Pucotenlimab and selective radiotherapy for locally advanced rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Pucotenlimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer, pMMR (Microsatellite Stable Rectal Cancer) | Phase 3 | Status: RECRUITING